Helen Torley Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen Torley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen Torley. Helen Torley is a Chief Opertaing Officer in ONYX PHARMACEUTICALS INC ($ONXX) and a EVP & Chief Commercial Officer in ONYX PHARMACEUTICALS INC ($ONXX) and a Director in QUEST DIAGNOSTICS INC ($DGX) and a President and CEO in HALOZYME THERAPEUTICS INC ($GYHT) and a Director in Relypsa Inc ($RLYP).
Address: C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO 94080 CA
Companies in which Helen Torley is an Insider
HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen Torley: President and CEO
Holdings: 587,160 shares
Latest Transaction: Jun 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ONYX PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen Torley: EVP & Chief Commercial Officer, Chief Opertaing Officer
Holdings: 58,701 shares
Latest Transaction: Aug 08 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUEST DIAGNOSTICS INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Helen Torley: Director
Holdings: 4,897 shares
Current Value: $453,560
Latest Transaction: May 21 2020
$DGX Market Capitalization: $12.75B
$DGX Previous Close: $92.62
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen Torley: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Helen Torley
Sentiment: All, GYHT, ONXX, DGX, RLYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 400,000 | |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 39.66 | 50,000 | 1,982,950 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Jun 07 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 500,000 | |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Sell | S | 42.55 | 50,000 | 2,127,250 | 537,160 | 587.2 K to 537.2 K (-8.52 %) |
| Apr 05 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 14.66 | 50,000 | 733,000 | 587,160 | 537.2 K to 587.2 K (+9.31 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 14.66 | 50,000 | 733,000 | 550,000 |